Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece--results of enhanced surveillance

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
A StathiP T Tassios

Abstract

Among a total of 101 isolates from the first systematic multicentre surveillance effort concerning invasive Streptococcus pyogenes disease in Greece, conducted between 2003 and 2005 and covering 38% of the population, emm types 1 and 12 were prevalent, being responsible for 27 and nine cases, respectively. The isolates from the remaining 65 cases were assigned to 26 other emm types. Erythromycin resistance (12 isolates) was primarily mef(A)-mediated, although all emm type 1 strains were susceptible. Tetracycline resistance, due mostly to tet(M), was detected in 26 isolates. Subtyping by pulsed-field gel electrophoresis yielded 50 chromosomal fingerprints, thus discriminating further among ten of the 28 observed emm types.

References

Dec 1, 1993·The Journal of Antimicrobial Chemotherapy·H SeppäläP Huovinen
Oct 1, 1993·Molecular and Cellular Probes·M C RobertsJ N Krieger
Sep 1, 1996·The Journal of Infectious Diseases·J StanleyR George
Feb 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P T TassiosN J Legakis
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·E TzelepiL S Tzouvelekis
Apr 12, 2000·The Journal of Antimicrobial Chemotherapy·A Efstratiou
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Mar 14, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G StamosM Foustoukou
Jan 9, 2003·Journal of Clinical Microbiology·Maria Pia MontanariPietro Emanuele Varaldo
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L ZachariadouP T Tassios
Aug 20, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S IoannidouA C Vatopoulos
Sep 10, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Maria SantagatiGianni Pozzi
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N FotopoulouN J Legakis
Dec 9, 2003·International Journal of Antimicrobial Agents·Sofia IoannidouAlkiviadis C Vatopoulos
Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hans Ulrik K NielsenNiels Frimodt-Møller
Sep 8, 2006·Journal of Clinical Microbiology·Katarzyna SzczypaWaleria Hryniewicz

❮ Previous
Next ❯

Citations

Jul 14, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Devrim DundarGulden Sonmez Tamer
Jun 12, 2013·Epidemiology and Infection·L ZachariadouUNKNOWN Hellenic Strep-Euro Study Group
Apr 28, 2009·Diagnostic Microbiology and Infectious Disease·Athanasios G MichosVassiliki P Syriopoulou
Aug 13, 2013·International Journal of Medical Microbiology : IJMM·Ana FriãesUNKNOWN Portuguese Group for the Study of Streptococcal Infections
Nov 13, 2015·Journal of Clinical Microbiology·Karen RudolphThomas Hennessy
Apr 18, 2018·Frontiers in Public Health·Giovanni GherardiRoberta Creti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
K B LauplandD B Gregson
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
C PlainvertCNR-Strep network
The Pediatric Infectious Disease Journal
G A SyrogiannopoulosN G Beratis
© 2022 Meta ULC. All rights reserved